Data from two studies show greater weight loss and comparable safety with a higher dose of semaglutide for those with and ...

A position paper argues that any systemic corticosteroid exposure in atopic dermatitis should trigger a transition to ...

Drug developer Arvinas said on Wednesday it will grant commercialization rights of an experimental breast cancer treatment it ...

Pfizer faces a significant patent cliff, pricing reforms, and limited financial flexibility from high debt, all threatening ...

Despite the two companies having submitted the oral PROteolysis TArgeting Chimera (PROTAC) ER degrader to the FDA for ...

Brepocitinib remains “ahead of competition” in the dermatomyositis space, according to analysts at Leerink, who projected ...

Roivant Sciences surges after positive Phase 3 brepocitinib data in dermatomyositis. Despite a strong pipeline, read why I ...

In Florida, as of Sept. 17, 2025, you do need a medical recommendation or prescription to receive a COVID vaccine at most ...

A drug licensed from Pfizer will be submitted to the FDA next year after study results showed it reduced dermatomyositis ...

Adults with atopic dermatitis, whether diagnosed during childhood or adulthood, experienced higher rates of suicidal thoughts ...

Also, fun note: My dad co-authored a First Opinion article for STAT on the potential impact of AI chatbots on psychosis. But ...

The World Health Organisation claims their roll-out prevented 14.4 million deaths worldwide in their first year, with some ...